Transplantation of Autologous Bone Marrow-Derived Cells into the Myocardium of Patients Undergoing Coronary Bypass

Abstract

This early clinical experience shows that autologous bone marrow-derived cell transplantation into myocardium is feasible and relatively safe. Further clinical trials to assess the role of cell transplantation for myocardial repair are required.